National Yang Ming Chiao Tung University

Jinn-Moon Yang

Yun-Ti Chen

Yun-Ming Wang

Ming-Lung Yu

Ya-Hui Wu

Jui-I Chao

Shey-Cherng Tzou

Yu-Hsiu Chang

Wan-Chun Liu

Yen-Chao Hsu

Hsiao-Chen Huang

Tzu-Ying Sung

Chinpiao Chen

Jung-Yu Lee

Nikhil Pathak

Hsin-Ping Lin

Kai-Cheng Hsu

Nung-Yu Hsu

Su-Pei Wang

Shen Rong Lin

Kai-Hao Yin

Chih-Heng Huang

Kuang-Mei Hsu

Po-Shiuan Hsieh

Disclosed herein is a method for alleviating a chronic liver disease, comprising administrating to a subject in need thereof a pharmaceutical composition containing rosoxacin.

Method for alleviating chronic liver disease using Rosoxacin

Disclosed herein is a method against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The method includes administering to a subject in need thereof a first active ingredient selected from the group consisting of methotrexate (MIX) and a pharmaceutically acceptable salt thereof, and a second active ingredient selected from the group consisting of remdesivir and a pharmaceutically acceptable salt thereof. A molar ratio of the first active ingredient to the second active ingredient ranges from 1:13 to 1:25.

Method against severe acute respiratory syndrome coronavirus 2 infection

The present invention provides a compound of formula (I) or the salt thereof: 

Selective inhibitors for protein kinases and pharmaceutical composition and use thereof

The present invention provides a compound of Formula (I) and a salt thereof, 

Compound for promoting apoptosis of cancer cells and a pharmaceutical composition containing the same and uses thereof

Growing community of inventors

Hsinchu, Taiwan

Jinn-Moon Yang